Purple Biotech (PPBT) Payables (2014 - 2026)
Purple Biotech (PPBT) reported Payables of $487,000 for Q2 2026, down 27.2% from $669,000 a year earlier and down 42.2% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Purple Biotech posted Payables of $2.07 million, up 42.3% from FY2024.
- Payables has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- By year, Payables came in at $1.46 million in FY2024 (-58.8%), $3.53 million in FY2023 (+65.7%), $2.13 million in FY2022 (+44.7%) and $1.47 million in FY2021 (+23.0%).
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q4 2017.
- Year over year, Payables gained in 1 of the last eight quarters, with an average decline of 36.8%.
- The high point for year-over-year Payables in five years was Q2 2024 (growth of 93.5%); the low point was Q2 2025 (a decline of 78.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $843,000 (Q1 2026), $2.07 million (Q4 2025) and $605,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | 487,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 487,000.00 |
| Mar 31, 2026 | 843,000.00 |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 605,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 2.08 Mn |
API Access
Purple Biotech Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();